Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
SKYWORTH GROUP LIMITED
創 維 集 團 有 限 公 司
(Incorporated in Bermuda with limited liability)
(Stock Code: 00751)
OVERSEAS REGULATORY ANNOUNCEMENT
FINANCIAL INFORMATION REGARDING
A SUBSIDIARY OF THE COMPANY
This announcement is made by the board of directors (the "Board") of Skyworth Group Limited (the "Company") pursuant to Rules 13.09(2) and 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and the Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).
Skyworth Group Co., Ltd.* (創維集團有限公司), a wholly-owned subsidiary of the Company established under the laws of the People's Republic of China, has disclosed its an unaudited consolidated financial statements for the three months ended 31 March 2021, which is reproduced in the appendix to this announcement.
The Subsidiary's financial information disclosed in this announcement is not an inducement to subscribe for or purchase any securities of the Company or other members of the Group, and no such inducement is intended. No investment decision should be based on such information.
By order of the Board
Skyworth Group Limited
Lai Weide
Chairman of the Board
Hong Kong, 27 April 2021
As at the date of this announcement, the Board of the Company comprises Mr. Lai Weide as the Chairman of the Board; Mr. Liu Tangzhi as executive director and the chief executive officer; Ms. Lin Wei Ping, Mr. Shi Chi, Mr. Lin Jin and Mr. Lam Shing Choi, Eric as executive directors; and Mr. Li Weibin, Mr. Cheong Ying Chew, Henry and Mr. Hung Ka Hai, Clement as independent non-executive directors.
* For identification purpose only
1
Appendix - the Subsidiary's financial information for three months ended 31 March 2021
Consolidated Balance Sheet
Prepared by: 創維集團有限公司 | As at 31 March 2021 | Unit: RMB | ||||
Assets | Closing balance | Opening Balance | Liabilities and shareholders' equity | Closing balance | Opening Balance | |
Current Assets: | Current Liabilities: | |||||
Bank balances and cash | 6,440,283,636.59 | 6,289,452,755.70 | Short-term loan | 5,065,146,690.92 | 5,225,201,540.32 | |
Balances with central bank | 496,272,478.20 | 272,126,712.78 | Borrowings from central bank | 1,812,250,230.54 | 1,917,446,972.15 | |
Placements with banks and other financial | 893,911,748.67 | 1,765,410,338.79 | Deposits from customers and interbank | 10,034,796.93 | 59,978,361.34 | |
institutions | ||||||
Financial assets held for trading | 810,644,616.10 | 511,615,724.18 | Interbank lending | - | - | |
Derivative financial assets | 8,244,014.33 | 9,366,411.85 | Derivative financial liabilities | 40,670,040.49 | 48,335,243.53 | |
Bills | receivables | 3,272,227,805.66 | 3,635,068,944.58 | Financial liabilities held for trading | - | - |
Trade | receivables | 9,620,118,819.57 | 9,588,775,997.63 | Bills payables | 1,697,730,000.34 | 1,829,262,292.41 |
Financing balance receivables | 158,112,790.26 | 399,680,411.93 | Trade payables | 8,916,097,543.15 | 8,427,650,532.79 | |
Prepayments | 578,056,813.35 | 482,663,281.50 | Receipts in advance | 23,497,213.68 | 21,604,612.88 | |
Other | receivables | 2,413,502,676.80 | 1,639,194,546.54 | Contract liabilities | 3,130,473,016.65 | 2,722,581,128.36 |
Redemptory monetary capital for sale | - | - | Wages and salaries payables | 685,896,870.85 | 788,940,612.89 | |
Inventories | 12,242,207,098.26 | 10,519,644,166.21 | Taxes and surcharges payables | 244,218,265.78 | 323,239,136.21 | |
Contract assets | - | - | Other payables | 4,217,276,800.14 | 4,364,001,431.89 | |
Held-for-sale assets | - | 199,844,394.75 | Held-for-sale liabilities | - | 83,672,283.91 | |
Non-current assets maturing within one year | 1,274,113,086.45 | 1,129,946,758.04 | Non-current liabilities maturing within | 662,480,880.93 | 568,602,293.57 | |
one year | ||||||
Other | current assets | 2,235,982,395.74 | 1,752,834,757.05 | Other current liabilities | 547,650,778.88 | 538,325,356.54 |
Total Current Assets | 40,443,677,979.98 | 38,195,625,201.53 | Total Current Liabilities | 27,053,423,129.28 | 26,918,841,798.79 | |
Non-current Assets: | Non-current Liabilities: | |||||
Loan receivables | 7,212,994.96 | 8,397,756.00 | Long-term borrowings | 5,063,873,319.70 | 3,057,535,075.69 | |
Finance lease receivables | 712,725.91 | 1,239,714.85 | Bonds payables | 1,721,006,593.76 | 1,709,827,642.13 | |
Factoring loan receivable | - | - | Lease liabilities | 821,909,314.89 | 772,547,594.43 | |
Debt investments | 472,290,318.28 | 589,242,712.90 | Long-term payables | 57,440.00 | 66,080.00 | |
Other debt investment | - | - | Provisions liabilities | 76,294,412.60 | 82,587,913.03 | |
Long-term receivables | - | - | Deferred income | 398,675,130.17 | 391,844,089.49 | |
Long-term equity investments | 453,159,670.41 | 415,119,064.24 | Deferred tax liabilities | 158,839,121.39 | 124,017,294.55 | |
Other equity instrument investments | 1,412,707,030.96 | 1,215,998,718.35 | Other non-current liabilities | 504,659,809.37 | 544,127,337.67 | |
Other non-current financial assets | 981,993,595.65 | 1,032,111,808.99 | Total Non-current Liabilities | 8,745,315,141.88 | 6,682,553,026.99 | |
Investment properties | 1,543,303,308.40 | 1,563,155,814.91 | Total Liabilities | 35,798,738,271.16 | 33,601,394,825.78 | |
Fixed assets | 3,519,061,445.15 | 3,427,451,177.54 | Owners' Equity: | |||
Construction-in-progress | 961,323,175.04 | 915,560,489.62 | Paid-up capital (Share capital) | 1,516,366,055.31 | 1,516,366,055.31 | |
Right-of-use assets | 858,729,379.49 | 869,695,787.69 | Other equity instruments | - | - | |
Intangible assets | 2,399,483,188.13 | 2,405,503,524.56 | Capital reserve | 2,498,190,272.84 | 2,498,826,013.37 | |
Development costs | 782,643.19 | 782,643.19 | Less: Treasury stock | - | - | |
Goodwill | 436,129,465.18 | 436,129,465.16 | Other comprehensive income | 277,370,650.95 | 157,751,648.57 | |
Long-term deferred expenses | 154,159,854.80 | 149,282,001.12 | Surplus reserve | 321,824,692.81 | 321,824,692.81 | |
Deferred tax assets | 527,987,593.99 | 485,476,666.03 | Provision for general risk | 117,281,131.04 | 117,281,131.04 | |
Other non-current assets | 243,051,905.73 | 223,566,270.78 | Retained earnings/Undistributed profit | 5,064,503,854.22 | 5,011,790,874.73 | |
Total Non-current Assets | 13,972,088,295.27 | 13,738,713,615.93 | Total equity attributable to the | 9,795,536,657.17 | 9,623,840,415.83 | |
owners of the company | ||||||
Non-controlling shareholders' equity | 8,821,491,346.92 | 8,709,103,576.85 | ||||
Total Owners' Equity | 18,617,028,004.09 | 18,332,943,992.68 | ||||
Total Assets | 54,415,766,275.25 | 51,934,338,817.46 | Total Liabilities and Owners' Equity | 54,415,766,275.25 | 51,934,338,818.46 |
2
Consolidated income statement
Prepared by: 創維集團有限公司 | For the 3 months ended 31 March 2021 | Unit: RMB | ||
Item | Current period | Same period of last year | ||
1. Revenue | 9,316,870,112.89 | 6,409,326,156.87 | ||
Less: | Cost of sales | 7,984,320,562.74 | 5,034,907,967.45 | |
Taxes and surcharges | 37,064,119.50 | 35,041,192.31 | ||
Selling expenses | 684,163,002.24 | 496,512,768.67 | ||
General and administrative expenses | 226,164,558.97 | 241,955,002.95 | ||
Research and development costs | 462,728,368.50 | 352,222,606.42 | ||
Finance costs | 91,644,152.05 | 133,643,975.65 | ||
Including: Interest income | 121,207,742.75 | 134,351,922.00 | ||
Interest expenses | 43,916,518.18 | 24,781,424.66 | ||
Add: | Other income | 163,358,003.23 | 146,265,458.94 | |
Investment income | 108,756,894.36 | 29,909,961.89 | ||
Including: Share of profits of associates and joint ventures | 1,090,606.17 | (9,855,362.33) | ||
Income from derecognition of financial assets at amortised cost | (2,311,457.86) | (5,111,443.36) | ||
Gain (loss) on fair values changes | 102,727,776.10 | (7,353,391.13) | ||
Gain (loss) on impairment of assets | 633,145.55 | (21,513,310.18) | ||
Gain (loss) on credit impairment | (14,767,766.16) | 40,497,589.03 | ||
Gain (loss) on disposal of assets | 2,240.19 | 1,362,608.62 | ||
2. Operating Profit | 191,495,642.16 | 304,211,560.59 | ||
Add: | Non-operating income | 21,228,416.91 | 7,230,277.50 | |
Less: | Non-operating expenses | 12,403,670.89 | (229,042.97) | |
3. Profit before tax | 200,320,388.18 | 311,670,881.06 | ||
Less: | Income tax expenses | 30,516,921.39 | 38,749,252.56 | |
4. Profit for the period | 169,803,466.79 | 272,921,628.50 | ||
Profit attributable to equity owners of the company | 53,657,725.44 | 137,457,383.00 | ||
Profit (loss) attributable to non-controlling interests | 116,145,741.35 | 135,464,245.50 | ||
5. Net other comprehensive income after tax | 163,517,033.99 | (240,885,113.53) | ||
Net other comprehensive income after tax attributable to owners of the parent | 119,619,002.35 | (164,439,900.62) | ||
company | ||||
(i) | Other comprehensive income not to be reclassified to profit or loss | 120,394,483.53 | (165,343,853.62) | |
1. Changes in the fair values of other equity instrument investments | 120,394,483.53 | (165,343,853.62) | ||
(ii) Other comprehensive income to be reclassified to profit or loss | (775,481.18) | 903,953.00 | ||
1. Exchange differences arising on translation of financial statements | (3,559,560.39) | 903,953.00 | ||
denominated in foreign currencies | ||||
2. Others | 2,784,079.21 | 0.00 | ||
Net other comprehensive income after tax attributable to non-controlling | 43,898,031.63 | (76,445,212.90) | ||
shareholders | ||||
6. Total comprehensive income | 333,320,500.78 | 32,036,514.97 | ||
Total comprehensive income attributable to owners of the parent company | 173,276,727.79 | (26,982,517.62) | ||
Total comprehensive income attributable to non-controlling shareholders | 160,043,772.98 | 59,019,032.60 | ||
3
Consolidated statement of cash flows
Prepared by: 創維集團有限公司 | For the 3 months ended 31 March 2021 | Unit: RMB | |
Cash flow items | Current period | Same period of last year | |
1. Cash flows from operating activities | |||
Proceeds from sales of commodities and rendering of services | 11,719,405,878.83 | 9,030,794,945.28 | |
Net increase in customer deposits and interbank deposits | 72,923,644.63 | 31,902,177.54 | |
Net increase in loan from other financial institutions | - | - | |
Interests, service charges and commission received | 15,715,463.31 | 17,628,068.63 | |
Taxes and surcharges refunded | 365,696,671.36 | 274,351,517.01 | |
Cash received from other operating activities | 1,196,328,090.02 | 1,592,468,309.23 | |
Subtotal of cash generated from operating activities | 13,370,069,748.15 | 10,947,145,017.69 | |
Payments for commodities and services | 10,850,388,867.35 | 6,810,257,213.65 | |
Net increase in customer deposits received and interbank deposits | 49,353,334.40 | 651,699,179.40 | |
Net increase in borrowings from central bank | 102,271,820.68 | 102,060,534.30 | |
Net increase in loans and advances to customers | 80,923,992.42 | (290,513,355.26) | |
Interests, service charges and commission paid | 18,933,260.75 | 2,471,538.00 | |
Cash paid to and for employees | 1,091,384,377.98 | 855,130,452.26 | |
Taxes and surcharges paid | 538,426,704.58 | 371,296,512.05 | |
Cash used in other operating activities | 1,976,234,337.50 | 2,128,054,386.41 | |
Subtotal of cash used in operating activities | 14,707,916,695.66 | 10,630,456,460.81 | |
Net cash flows from operating activities | (1,337,846,947.51) | 316,688,556.88 | |
2. Cash flows from investing activities | |||
Proceeds from realisation of investment | 169,295,717.58 | 656,250,594.62 | |
Proceeds from returns on investments | 34,506,366.49 | 52,416,291.06 | |
Net proceeds from disposal of fixed assets, intangible assets and other | 6,967,154.22 | 1,492,834.02 | |
long-term assets | |||
Net proceeds from disposal of subsidiaries and other operating units | - | (18,284.06) | |
Cash received from other investing activities | 71,660,602.06 | 5,546,630.30 | |
Subtotal of cash generated from investing activities | 282,429,840.35 | 715,688,065.94 | |
Payments for acquisition of fixed assets, intangible assets and other | 402,635,678.51 | 263,724,825.85 | |
long-term assets | |||
Payments for investments | 499,395,693.90 | 846,902,795.84 | |
Net increase in pledged loan | - | - | |
Payments for acquisition of subsidiaries and other operating units | - | - | |
Cash used in other investing activities | 112,712,645.95 | (13,603.64) | |
Subtotal of cash used in investing activities | 1,014,744,018.36 | 1,110,614,018.05 | |
Net cash flows from investing activities | (732,314,178.01) | (394,925,952.11) | |
3. Cash flows from financing activities | |||
Cash received from capital contribution | 74,891,000.00 | 29,590,000.00 | |
Cash received from borrowings | 4,362,993,840.22 | 5,292,940,233.67 | |
Cash received from other financing activities | 2,390,628.84 | 776,911,269.42 | |
Subtotal of cash generated from financing activities | 4,440,275,469.06 | 6,099,441,503.09 | |
Repayment of borrowings | 2,485,496,150.45 | 4,228,132,247.80 | |
Distribution of dividends or profits and payments for interest expenses | 111,658,929.96 | 125,287,864.20 | |
Cash used in other financing activities | 50,327,499.98 | 496,068,508.56 | |
Subtotal of cash used in financing activities | 2,647,482,580.39 | 4,849,488,620.56 | |
Net cash flows from financing activities | 1,792,792,888.67 | 1,249,952,882.53 | |
4. Effect of foreign exchange rate changes | (12,011,685.97) | 8,414,885.05 | |
5. Net increase in cash and cash equivalents | (289,379,922.82) | 1,180,130,372.35 | |
Add: Cash and cash equivalents at beginning of the period | 6,930,131,728.29 | 4,068,030,758.83 | |
6. Cash and cash equivalents at end of the period | 6,640,751,805.47 | 5,248,161,131.18 |
4
Attachments
- Original document
- Permalink
Disclaimer
Skyworth Digital Holdings Limited published this content on 27 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 April 2021 11:42:03 UTC.